Award
NIH Reporter #5R01HL162960-04
Mineralocorticoid receptor, coronary microvascular function, and cardiac efficiency in hypertension
Recipient
Brigham and Women's Hospital
Award Amount
$759,113.00
Ceiling
$759,113.00
Awarded
April 21, 2026
Identifier
5R01HL162960-04
NIH grant awarded by NHLBI for clinical research on hypertension to study mineralocorticoid receptor blockade effects on cardiac function, totaling $759,113 for FY 2026.
Description
The project involves clinical research on hypertension, focusing on mineralocorticoid receptor blockade to improve microvascular and cardiac efficiency. The study will use cardiac PET/CT, echocardiography, and BP monitoring. The project is funded by NHLBI, with a total award of $759,113 for FY 2026. The project start date is January 1, 2023, and end date is December 31, 2026. The primary organization is Brigham and Women's Hospital in Boston.